LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the launch of its first product in the spinal biologics market, the VIKOS™ Cervical Allograft System. K2M worked with LifeNet Health™, a leading allograft bio-implant and regenerative medicine company, to combine quality machined allograft implants with precision instrumentation.
